Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/7/2016
BGI Suffers IPO Blow As Regulators Terminate Review
11/7/2016
Chinese Medicine Law Stirs Debate Between Scholars and Skeptics
11/7/2016
Roche Begins Construction of CNY 860M Innovation Center in Shanghai
11/7/2016
Data Snapshot - Chinese Hospital Anti-infective Drug Consumption Up 4....
11/7/2016
CFDA Seeks Comments on Guidelines for Equivalence Study of Generics wi...
11/7/2016
CFDA Seeks Comments on Guidelines for Equivalence Study of Generics wi...
11/7/2016
China Issues Pharmaceutical Industry Development Guidelines
11/6/2016
The State of Mental Health in Asia Pacific
11/4/2016
NDRC Drafts Negative List for Internet Market, Banning Online Sales of...
11/4/2016
CFDA to Initiate Clinical Data Inspection of 55 Drug Applications
11/4/2016
Review of Chinese Digestive System and Metabolism Drug Market in 2015
11/4/2016
Recent Executive Moves
11/4/2016
NHFPC Solicits Public Comments on Physician Licensing and Medical Inst...
11/4/2016
Merck KGaA Adds EUR 250M Investment for New Plant and Reseach Center i...
11/2/2016
FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China
11/2/2016
Alphamab Starts Clinical Trial on Its First Novel Biologics KN015 for ...
11/2/2016
OncoVent Initiates Clinical Development Program for Anti-MUC1 MAb AR20...
11/2/2016
Innovative Medical to Buy 17% Stake in Israeli Cell Therapy Startup Pl...
11/2/2016
Backed by China, Ambrx No Longer Dependent on Partnerships with MNCs
11/2/2016
U.S. FDA Warns Yet Another Chinese API Manufacturer for Violations
11/2/2016
Intec Granted Chinese Patent for Accordion Pill Carbidopa/Levodopa
11/2/2016
With China's Approval of Prevenar 13(R), Pfizer Is to Restart Vaccine ...
11/2/2016
NHFPC Leadership Meets Visiting U.S. Health, Commerce Joint Delegation
11/1/2016
Medbanks and QuintilesIMS Enter Starategic Partnership for Oncology Da...
11/1/2016
USP and Chinese Pharmacopeia Extend Partnership
11/1/2016
Fostering a Sustainable Ecosystem for "Healthy China 2030" -...
11/1/2016
China Powers Ahead with Healthcare Reform despite Unanswered Questions...
11/1/2016
CFDA Official Highlights Key Areas of Ongoing Drug Regulatory Reform
11/1/2016
CFDA Issues GCP for Clinical Research of Medical Purpose Food Products
11/1/2016
TaiGen, HEC to Form a JV for New Chronic HCV Cocktail Drug
Page:
329
/
720
Total number of articles:
21594
:
[First]
[<<]
[327]
[328]
[329]
[330]
[331]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit